𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles

✍ Scribed by Joseph Kattan; Jean-Pierre Droz; Patrick Couvreur; Jean-Pierre Marino; Arnaud Boutan-Laroze; Philippe Rougier; Philippe Brault; Henri Vranckx; Jean-Marc Grognet; Xavier Morge; Hélène Sancho-Garnier

Publisher
Springer US
Year
1992
Tongue
English
Weight
619 KB
Volume
10
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An evaluation of phase I cancer clinical
An evaluation of phase I cancer clinical trial designs
✍ Chul Ahn 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Phase I clinical trials are designed to identify an appropriate dose for experimentation in phase II and III studies. I present the results from a simulation study to evaluate the performance of nine phase I designs involving the standard design, the two-stage modified Storer's design, the two-stage

Phase I clinical trial and pharmacokinet
Phase I clinical trial and pharmacokinetics of weekly ICRF-187 (NSC 169780) infusion in patients with solid tumors
✍ Charles L. Vogel; Elizabeth Gorowski; Enrique Davila; Mario Eisenberger; James K 📂 Article 📅 1987 🏛 Springer US 🌐 English ⚖ 823 KB

ICRF-187 was given to 62 evaluable patients with advanced solid tumors in a Phase I clinical trial. Weekly infusions were given in dosages ranging from 0.85 g/m2 to 7.42 g/m2 for a total of four weeks with a two week rest period between courses. Dose-limiting hematological toxicity was seen in heavi